Collectively, our findings indicate that expression of IL-1R8 represents a novel immunomodulatory mechanism leading to impaired innate immune sensing and antitumor immunity and provides new insights to cancer immunotherapy. The gene discussed is IL1RAPL1; the disease is cancer.